Very reassuring strength and durability of the #SARSVoV2 immune response from an mRNA (@moderna_tx) vaccine across the ages and through 4 months @NEJM today https://t.co/mIOWd91bwo @NIAIDNews @NIH pic.twitter.com/17YLFtpVnP

— Eric Topol (@EricTopol) December 3, 2020